292 related articles for article (PubMed ID: 34885056)
1. The Serine Protease CD26/DPP4 in Non-Transformed and Malignant T Cells.
Chitadze G; Wehkamp U; Janssen O; Brüggemann M; Lettau M
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885056
[TBL] [Abstract][Full Text] [Related]
2. Degranulation of human cytotoxic lymphocytes is a major source of proteolytically active soluble CD26/DPP4.
Lettau M; Dietz M; Vollmers S; Armbrust F; Peters C; Dang TM; Chitadze G; Kabelitz D; Janssen O
Cell Mol Life Sci; 2020 Feb; 77(4):751-764. PubMed ID: 31300870
[TBL] [Abstract][Full Text] [Related]
3. Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.
Klemann C; Wagner L; Stephan M; von Hörsten S
Clin Exp Immunol; 2016 Jul; 185(1):1-21. PubMed ID: 26919392
[TBL] [Abstract][Full Text] [Related]
4. Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice.
Nishina S; Yamauchi A; Kawaguchi T; Kaku K; Goto M; Sasaki K; Hara Y; Tomiyama Y; Kuribayashi F; Torimura T; Hino K
Cell Mol Gastroenterol Hepatol; 2019; 7(1):115-134. PubMed ID: 30510994
[TBL] [Abstract][Full Text] [Related]
5. The CD26/DPP4-inhibitor vildagliptin suppresses lung cancer growth via macrophage-mediated NK cell activity.
Jang JH; Janker F; De Meester I; Arni S; Borgeaud N; Yamada Y; Gil Bazo I; Weder W; Jungraithmayr W
Carcinogenesis; 2019 Apr; 40(2):324-334. PubMed ID: 30698677
[TBL] [Abstract][Full Text] [Related]
6. Targeting cluster of differentiation 26 / dipeptidyl peptidase 4 (CD26/DPP4) in organ fibrosis.
Ohm B; Moneke I; Jungraithmayr W
Br J Pharmacol; 2023 Nov; 180(22):2846-2861. PubMed ID: 36196001
[TBL] [Abstract][Full Text] [Related]
7. CD26/DPP4 levels in peripheral blood and T cells in patients with type 2 diabetes mellitus.
Lee SA; Kim YR; Yang EJ; Kwon EJ; Kim SH; Kang SH; Park DB; Oh BC; Kim J; Heo ST; Koh G; Lee DH
J Clin Endocrinol Metab; 2013 Jun; 98(6):2553-61. PubMed ID: 23539735
[TBL] [Abstract][Full Text] [Related]
8. CD26/DPP4 - a potential biomarker and target for cancer therapy.
Enz N; Vliegen G; De Meester I; Jungraithmayr W
Pharmacol Ther; 2019 Jun; 198():135-159. PubMed ID: 30822465
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory effects on ischemia/reperfusion-injured lung transplants by the cluster of differentiation 26/dipeptidylpeptidase 4 (CD26/DPP4) inhibitor vildagliptin.
Jang JH; Yamada Y; Janker F; De Meester I; Baerts L; Vliegen G; Inci I; Chatterjee S; Weder W; Jungraithmayr W
J Thorac Cardiovasc Surg; 2017 Mar; 153(3):713-724.e4. PubMed ID: 27939504
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Perspectives of CD26 Inhibitors in Imune-Mediated Diseases.
Hu X; Wang X; Xue X
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889373
[TBL] [Abstract][Full Text] [Related]
11. CD26/dipeptidyl peptidase 4-deficiency alters thymic emigration patterns and leukcocyte subsets in F344-rats age-dependently.
Klemann C; Schade J; Pabst R; Leitner S; Stiller J; von Hörsten S; Stephan M
Clin Exp Immunol; 2009 Feb; 155(2):357-65. PubMed ID: 19055685
[TBL] [Abstract][Full Text] [Related]
12. Functional Roles for CD26/DPP4 in Mediating Inflammatory Responses of Pulmonary Vascular Endothelial Cells.
Takahashi Y; Kawasaki T; Sato H; Hasegawa Y; Dudek SM; Ohara O; Tatsumi K; Suzuki T
Cells; 2021 Dec; 10(12):. PubMed ID: 34944016
[TBL] [Abstract][Full Text] [Related]
13. Cellular expression of CD26/dipeptidyl peptidase IV.
Iwanaga T; Nio-Kobayashi J
Biomed Res; 2021; 42(6):229-237. PubMed ID: 34937822
[TBL] [Abstract][Full Text] [Related]
14. Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme.
Matteucci E; Giampietro O
Curr Med Chem; 2009; 16(23):2943-51. PubMed ID: 19689275
[TBL] [Abstract][Full Text] [Related]
15. CD26-Related Serum Biomarkers: sCD26 Protein, DPP4 Activity, and Anti-CD26 Isotype Levels in a Colorectal Cancer-Screening Context.
De Chiara L; Páez de la Cadena M; Rodríguez-Berrocal J; Alvarez-Pardiñas MC; Pardiñas-Añón MC; Varela-Calviño R; Cordero OJ
Dis Markers; 2020; 2020():4347936. PubMed ID: 32051696
[TBL] [Abstract][Full Text] [Related]
16. Dipeptidyl peptidase IV (DPP4) deficiency increases Th1-driven allergic contact dermatitis.
Tasic T; Bäumer W; Schmiedl A; Schwichtenhövel F; Pabst R; Raap U; von Hörsten S; Stephan M
Clin Exp Allergy; 2011 Aug; 41(8):1098-107. PubMed ID: 21672052
[TBL] [Abstract][Full Text] [Related]
17. Suppression of lung metastases by the CD26/DPP4 inhibitor Vildagliptin in mice.
Jang JH; Baerts L; Waumans Y; De Meester I; Yamada Y; Limani P; Gil-Bazo I; Weder W; Jungraithmayr W
Clin Exp Metastasis; 2015 Oct; 32(7):677-87. PubMed ID: 26233333
[TBL] [Abstract][Full Text] [Related]
18. Identifying neuropeptide Y (NPY) as the main stress-related substrate of dipeptidyl peptidase 4 (DPP4) in blood circulation.
Wagner L; Kaestner F; Wolf R; Stiller H; Heiser U; Manhart S; Hoffmann T; Rahfeld JU; Demuth HU; Rothermundt M; von Hörsten S
Neuropeptides; 2016 Jun; 57():21-34. PubMed ID: 26988064
[TBL] [Abstract][Full Text] [Related]
19. Systemic DPP4/CD26 is associated with natural HIV-1 control: Implications for COVID-19 susceptibility.
Govender Y; Shalekoff S; Ebrahim O; Waja Z; Chaisson RE; Martinson N; Tiemessen CT
Clin Immunol; 2021 Sep; 230():108824. PubMed ID: 34391936
[TBL] [Abstract][Full Text] [Related]
20. CD4
Vonderheid EC; Hou JS
Leuk Lymphoma; 2018 Feb; 59(2):330-339. PubMed ID: 28595473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
